Cargando…
PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis
Giant cell arteritis (GCA) is one of the commonest forms of vasculitis in the elderly, and may result in blindness and stroke. The pathogenesis of GCA is not understood, although environmental, infectious and genetic risk factors are implicated. One gene of interest is PTPN22, encoding lymphoid prot...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838769/ https://www.ncbi.nlm.nih.gov/pubmed/27110387 http://dx.doi.org/10.1136/rmdopen-2016-000246 |
_version_ | 1782428029419520000 |
---|---|
author | Lester, Susan Hewitt, Alex W Ruediger, Carlee D Bradbury, Linda De Smit, Elisabeth Wiese, Michael D Black, Rachel Harrison, Andrew Jones, Graeme Littlejohn, Geoffrey O Merriman, Tony R Shenstone, Bain Smith, Malcolm D Rischmueller, Maureen Brown, Matthew A Hill, Catherine L |
author_facet | Lester, Susan Hewitt, Alex W Ruediger, Carlee D Bradbury, Linda De Smit, Elisabeth Wiese, Michael D Black, Rachel Harrison, Andrew Jones, Graeme Littlejohn, Geoffrey O Merriman, Tony R Shenstone, Bain Smith, Malcolm D Rischmueller, Maureen Brown, Matthew A Hill, Catherine L |
author_sort | Lester, Susan |
collection | PubMed |
description | Giant cell arteritis (GCA) is one of the commonest forms of vasculitis in the elderly, and may result in blindness and stroke. The pathogenesis of GCA is not understood, although environmental, infectious and genetic risk factors are implicated. One gene of interest is PTPN22, encoding lymphoid protein tyrosine phosphatase (Lyp), expressed exclusively in immune cells, which is proposed to be an ‘archetypal non-HLA autoimmunity gene’. The minor allele of a functional PTPN22 single nucleotide polymorphism (rs2476601, R620W), which disrupts an interaction motif in the protein, was originally reported to be associated with biopsy-proven GCA in Spanish patients, with supporting data from three replicate Northern European studies. Recently, this observation was extended with additional patients and controls, and studies encompassing European, Scandinavian, UK and American patients. The aim of our study was to determine the association between PTPN22 rs2476601 (R620W) and biopsy-proven GCA in an Australian case cohort. |
format | Online Article Text |
id | pubmed-4838769 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-48387692016-04-22 PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis Lester, Susan Hewitt, Alex W Ruediger, Carlee D Bradbury, Linda De Smit, Elisabeth Wiese, Michael D Black, Rachel Harrison, Andrew Jones, Graeme Littlejohn, Geoffrey O Merriman, Tony R Shenstone, Bain Smith, Malcolm D Rischmueller, Maureen Brown, Matthew A Hill, Catherine L RMD Open Vasculitis Giant cell arteritis (GCA) is one of the commonest forms of vasculitis in the elderly, and may result in blindness and stroke. The pathogenesis of GCA is not understood, although environmental, infectious and genetic risk factors are implicated. One gene of interest is PTPN22, encoding lymphoid protein tyrosine phosphatase (Lyp), expressed exclusively in immune cells, which is proposed to be an ‘archetypal non-HLA autoimmunity gene’. The minor allele of a functional PTPN22 single nucleotide polymorphism (rs2476601, R620W), which disrupts an interaction motif in the protein, was originally reported to be associated with biopsy-proven GCA in Spanish patients, with supporting data from three replicate Northern European studies. Recently, this observation was extended with additional patients and controls, and studies encompassing European, Scandinavian, UK and American patients. The aim of our study was to determine the association between PTPN22 rs2476601 (R620W) and biopsy-proven GCA in an Australian case cohort. BMJ Publishing Group 2016-04-07 /pmc/articles/PMC4838769/ /pubmed/27110387 http://dx.doi.org/10.1136/rmdopen-2016-000246 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Vasculitis Lester, Susan Hewitt, Alex W Ruediger, Carlee D Bradbury, Linda De Smit, Elisabeth Wiese, Michael D Black, Rachel Harrison, Andrew Jones, Graeme Littlejohn, Geoffrey O Merriman, Tony R Shenstone, Bain Smith, Malcolm D Rischmueller, Maureen Brown, Matthew A Hill, Catherine L PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis |
title | PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis |
title_full | PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis |
title_fullStr | PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis |
title_full_unstemmed | PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis |
title_short | PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis |
title_sort | ptpn22 r620w minor allele is a genetic risk factor for giant cell arteritis |
topic | Vasculitis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838769/ https://www.ncbi.nlm.nih.gov/pubmed/27110387 http://dx.doi.org/10.1136/rmdopen-2016-000246 |
work_keys_str_mv | AT lestersusan ptpn22r620wminoralleleisageneticriskfactorforgiantcellarteritis AT hewittalexw ptpn22r620wminoralleleisageneticriskfactorforgiantcellarteritis AT ruedigercarleed ptpn22r620wminoralleleisageneticriskfactorforgiantcellarteritis AT bradburylinda ptpn22r620wminoralleleisageneticriskfactorforgiantcellarteritis AT desmitelisabeth ptpn22r620wminoralleleisageneticriskfactorforgiantcellarteritis AT wiesemichaeld ptpn22r620wminoralleleisageneticriskfactorforgiantcellarteritis AT blackrachel ptpn22r620wminoralleleisageneticriskfactorforgiantcellarteritis AT harrisonandrew ptpn22r620wminoralleleisageneticriskfactorforgiantcellarteritis AT jonesgraeme ptpn22r620wminoralleleisageneticriskfactorforgiantcellarteritis AT littlejohngeoffreyo ptpn22r620wminoralleleisageneticriskfactorforgiantcellarteritis AT merrimantonyr ptpn22r620wminoralleleisageneticriskfactorforgiantcellarteritis AT shenstonebain ptpn22r620wminoralleleisageneticriskfactorforgiantcellarteritis AT smithmalcolmd ptpn22r620wminoralleleisageneticriskfactorforgiantcellarteritis AT rischmuellermaureen ptpn22r620wminoralleleisageneticriskfactorforgiantcellarteritis AT brownmatthewa ptpn22r620wminoralleleisageneticriskfactorforgiantcellarteritis AT hillcatherinel ptpn22r620wminoralleleisageneticriskfactorforgiantcellarteritis |